Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension: The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment). Hypertension. 2018 Apr;71(4):681-690. https://www.ncbi.nlm.nih.gov/pubmed/29463627 #VisualAbstract by ISN Education @ISNeducation #Spironolactone #Clonidine #Resistant #Hypertension #ReHOT #EBM
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief π΅π πΊπΈ - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG: https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/